160 likes | 214 Views
Learn about the benefits and drawbacks of preoperative chemoradiotherapy for colorectal cancer. Review of literature on various treatment approaches and their impact on local recurrence rates, survival, and post-operative outcomes.
E N D
Preoperative CCRT in Colorectal Cancer 嘉義長庚醫院 大腸直腸外科 葉重宏
The Goal of Pre-OP CCRT • Radical resection is the principal treatment of rectal carcinoma • Unfortunately, the local recurrence rate is 30 ~ 50 % • The carcinoma of rectum is relative sensitive to irradiation • 5-FU is a chemo-sensitizer • Adjuvant therapy with chemo-radiation has been employed
The Advantage of Pre-OP CCRT • Increase the resectability • Increase the possibility of curative resection • Down-staging of the resected cancer • Reduce the local and distal relapses • Increase the chance of sphincter-preserving operation
The Disadvantage of Pre-OP CCRT • Under-estimate the surgical staging • Over treatment for early rectal cancer -- 20 % ~ 30 % of CCRT is T1 or T2 • Potential increase the operative morbidity and mortality • Delay the operation
Review of literature (1) • EORTC ( European Organization for Research and Treatment of Cancer ) -1988 3450cGy pre-OP irradiation Local recurrence rate decrease Increase post-OP perineal wound infection and hospital stay No difference in long term survival
Review of literature (2) • Stockholm Rectal Cancer study group–1990 2500 cGy over 5 ~ 7 days Reduce pelvic recurrence No difference in distal metastasis and over-all survival. Prolong the time of local recurrence and distal metastasis Increase in post –OP morbidity
Review of literature (3) • Pahlman and Glimelius – 1990 2550 cGy in 5 to 7 days No radiation-related complication nor increase mortality Lower local recurrence Equal survival • Mendenhall -1992 Local recurrence 8 % vs. 33 % 5-year survival rate 66 % vs. 40 %
Review of literature (4) • Swedish multicenter study (1)– 1993 2500 cGy in 5 days No increase in post –OP mortality Increase in perineal wound infection No increase in anastomotic dehiscence or other post-OP complication • Swedish multicenter study (2)– 1995 No increase in post –OP mortality Decrease in local recurrence
Review of literature (5) • Swedish multicenter study (3) – 1996 4-field box technique Reduce treatment volume Reduce local recurrence Improve survival length No significant increase mortality
Review of literature (6) • Holm et al. – 1995 2500 cGy in 5 ~ 7 days Increase in perineal wound infection –APR No increase in anastomotic leakage –AR No increase in post-OP mortality –APR and AR Reduce in local recurrence – APR and AR No difference in survival –APR and AR
Review of literature (7) • Kerman et al. – 1992 4500 ~ 5000 cGy No treatment related mortality Low post-Op complication rate -- 5.2 % Low local recurrence rate – 4.2 % Low distal failure rate – 10.5 % 5 year survival 66 % Disease-free survival rate 64 % 10 year survival 52 %
Review of literature (8) • Bannon et al. – 1995 4500 ~ 7000 cGy AAR vs full thickness local excision Local recurrence 9 % and 14 % 5 year survival rate 85 % and 90 % • Minsky et al. – 1995 4680 cGy + 360 cGy LAR and coloanal anastomosis Local recurrence 12 % 4 year survival 75 %
Review of literature (9) • Myerson et al. – 1995 Izar et al. – 1992 3600 cGy ~ 5000 cGy Local control 88 %~ 90 % 5 year disease-free survival 70 %~73 % 10 year-survival 50 %
Summary (1) • Improvement in radiation Prone position Multi-field technique Computerized dosimetry High energy linear accelerator Bladder distension Standard fraction size ( 180~200 cGy ) • Frequent protocol 4000 ~ 4500 cGy in 4 ~ 6 weeks 6 weeks interval before operation • Protective colostomy Not necessary if dose < 4500 cGy
Summary (2) • Improve the resectability • Destroy the Malignant cells in regional LN – down-staging • Increase local control • Alter the viability of the shed malignant cell – May decrease distant dissemination